These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21570793)

  • 1. Fusion of dynamic contrast-enhanced magnetic resonance mammography at 3.0T with X-ray mammograms: pilot study evaluation using dedicated semi-automatic registration software.
    Dietzel M; Hopp T; Ruiter N; Zoubi R; Runnebaum IB; Kaiser WA; Baltzer PA
    Eur J Radiol; 2011 Aug; 79(2):e98-e102. PubMed ID: 21570793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complete software application for automatic registration of x-ray mammography and magnetic resonance images.
    Solves-Llorens JA; Rupérez MJ; Monserrat C; Feliu E; García M; Lloret M
    Med Phys; 2014 Aug; 41(8):081903. PubMed ID: 25086534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of free-form deformation registration for dynamic contrast-enhanced MR mammography.
    Tanner C; Schnabel JA; Hill DL; Hawkes DJ; Degenhard A; Leach MO; Hose DR; Hall-Craggs MA; Usiskin SI
    Med Phys; 2007 Apr; 34(4):1221-33. PubMed ID: 17500454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
    Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
    Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
    Gokalp G; Topal U; Yildirim N; Tolunay S
    Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging.
    Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI
    J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast lesion co-localisation between X-ray and MR images using finite element modelling.
    Lee AW; Rajagopal V; Babarenda Gamage TP; Doyle AJ; Nielsen PM; Nash MP
    Med Image Anal; 2013 Dec; 17(8):1256-64. PubMed ID: 23860392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic multimodal 2D/3D breast image registration using biomechanical FEM models and intensity-based optimization.
    Hopp T; Dietzel M; Baltzer PA; Kreisel P; Kaiser WA; Gemmeke H; Ruiter NV
    Med Image Anal; 2013 Feb; 17(2):209-18. PubMed ID: 23265802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of controlled aliasing in parallel imaging results in a higher acceleration (CAIPIRINHA)-volumetric interpolated breathhold (VIBE) sequence for gadoxetic acid-enhanced liver MR imaging.
    Yu MH; Lee JM; Yoon JH; Kiefer B; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Nov; 38(5):1020-6. PubMed ID: 23559147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New trends and novel possibilities in the diagnostic imaging of breast cancer].
    Bidlek M; Kovács E; Fehér K; Gõdény M
    Magy Onkol; 2015 Mar; 59(1):44-55. PubMed ID: 25763913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI to X-ray mammography registration using a volume-preserving affine transformation.
    Mertzanidou T; Hipwell J; Cardoso MJ; Zhang X; Tanner C; Ourselin S; Bick U; Huisman H; Karssemeijer N; Hawkes D
    Med Image Anal; 2012 Jul; 16(5):966-75. PubMed ID: 22513136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of contrast-enhanced breast MR and mammographic imaging data.
    Behrenbruch CP; Marias K; Armitage PA; Yam M; Moore N; English RE; Clarke J; Brady M
    Med Image Anal; 2003 Sep; 7(3):311-40. PubMed ID: 12946471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.